2015
DOI: 10.1155/2015/726471
|View full text |Cite
|
Sign up to set email alerts
|

Yokukansan Increases 5-HT1AReceptors in the Prefrontal Cortex and Enhances 5-HT1AReceptor Agonist-Induced Behavioral Responses in Socially Isolated Mice

Abstract: The traditional Japanese medicine yokukansan has an anxiolytic effect, which occurs after repeated administration. In this study, to investigate the underlying mechanisms, we examined the effects of repeated yokukansan administration on serotonin 1A (5-HT1A) receptor density and affinity and its expression at both mRNA and protein levels in the prefrontal cortex (PFC) of socially isolated mice. Moreover, we examined the effects of yokukansan on a 5-HT1A receptor-mediated behavioral response. Male mice were sub… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(14 citation statements)
references
References 43 publications
1
13
0
Order By: Relevance
“…These multiple potential actions include serotonergic, glutamatergic, cholinergic, dopaminergic, adrenergic, and GABAnergic neurotransmissions as well as neuroprotection, anti-stress effect, promotion of neuroplasticity, and anti-inflammatory effect [ 63 ]. Among these neuropsychopharmacological effects, YKS, Uncaria hook, or GM has been demonstrated to enhance 5-HT 1A receptor agonist-induced decrease in rearing behavior, concomitant with up-regulation of prefrontal 5-HT 1A receptors in mice [ 64 ], or to ameliorate aggressiveness and decreased sociability [ 10 ] in isolation-stressed mice, anxiety in fear-conditioned rats [ 65 , 66 ] through their agonistic effect to 5-HT 1A receptors [ 10 ], 5-hydroxy-L-tryptophan-induced head-twitch response which are related to 5-HT 2A and 5-HT 2C receptor antagonisms [ 18 ], and 5-HT 2A receptor agonist-induced head-twitch response by down-regulating 5-HT 2A receptors in the prefrontal cortex [ 67 , 68 ]. In addition, these substances act on other neurotransmitter systems to improve symptoms, e.g., adrenergic/dopaminergic agonist-induced decrease in locomotion [ 18 , 69 ], morphine-induced tolerance/physical dependency in mice by blocking α 2A -adrenoceptors [ 70 ], norepinephrine-induced contraction of rat aorta [ 22 ], and glutamate-induced neuronal death [ 71 ].…”
Section: Pharmacological Aspectmentioning
confidence: 99%
“…These multiple potential actions include serotonergic, glutamatergic, cholinergic, dopaminergic, adrenergic, and GABAnergic neurotransmissions as well as neuroprotection, anti-stress effect, promotion of neuroplasticity, and anti-inflammatory effect [ 63 ]. Among these neuropsychopharmacological effects, YKS, Uncaria hook, or GM has been demonstrated to enhance 5-HT 1A receptor agonist-induced decrease in rearing behavior, concomitant with up-regulation of prefrontal 5-HT 1A receptors in mice [ 64 ], or to ameliorate aggressiveness and decreased sociability [ 10 ] in isolation-stressed mice, anxiety in fear-conditioned rats [ 65 , 66 ] through their agonistic effect to 5-HT 1A receptors [ 10 ], 5-hydroxy-L-tryptophan-induced head-twitch response which are related to 5-HT 2A and 5-HT 2C receptor antagonisms [ 18 ], and 5-HT 2A receptor agonist-induced head-twitch response by down-regulating 5-HT 2A receptors in the prefrontal cortex [ 67 , 68 ]. In addition, these substances act on other neurotransmitter systems to improve symptoms, e.g., adrenergic/dopaminergic agonist-induced decrease in locomotion [ 18 , 69 ], morphine-induced tolerance/physical dependency in mice by blocking α 2A -adrenoceptors [ 70 ], norepinephrine-induced contraction of rat aorta [ 22 ], and glutamate-induced neuronal death [ 71 ].…”
Section: Pharmacological Aspectmentioning
confidence: 99%
“…Arai et al reported that Kampo prescription to manage psychological symptoms such as yokukansan, kamishoyosan, and kososan was used for psychopathological patients suffering from chronic pain in a multidisciplinary pain center . For example, yokukansan can influence several neurotransmitters and receptors such as serotonergic and glutamate receptors, which can provide a significant degree of control over the entire body. KM can contribute to controlling anxiety with somatic and psychological symptoms, even when the patient's condition remains unidentified.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the partial agonist effect of YKS on 5‐HT 1A receptors may explain the positive effects of YKS on aggressive and anxiety‐like behaviors. Finally, YKS has been shown to increase expression of 5‐HT 1A receptors in the prefrontal cortex of socially isolated mice .…”
Section: Neuropharmacological Effectsmentioning
confidence: 96%